EMIS has been selected for the GP IT Futures framework, securing it the opportunity to continue to sell its core clinical GP software in England. Despite the change from per practice to per patient charging, management expects to receive broadly similar payments. In our view, the risk of increased competition in the core systems market should be weighed against the potential to generate incremental sales of catalogue solutions.
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.